Early growth response 1 exacerbates thoracic aortic aneurysm and dissection of mice by inducing the phenotypic switching of vascular smooth muscle cell through the activation of Krüppel-like factor 5
- PMID: 39345002
- DOI: 10.1111/apha.14237
Early growth response 1 exacerbates thoracic aortic aneurysm and dissection of mice by inducing the phenotypic switching of vascular smooth muscle cell through the activation of Krüppel-like factor 5
Abstract
Aim: Vascular smooth muscle cell (VSMC) phenotypic switching has been reported to regulate vascular function and thoracic aortic aneurysm and dissection (TAAD) progression. Early growth response 1 (Egr1) is associated with the differentiation of VSMCs. However, the mechanisms through which Egr1 participates in the regulation of VSMCs and progression of TAAD remain unknown. This study aimed to investigate the role of Egr1 in the phenotypic switching of VSMCs and the development of TAAD.
Methods: Wild-type C57BL/6 and SMC-specific Egr1-knockout mice were used as experimental subjects and fed β-aminopropionitrile for 4 weeks to construct the TAAD model. Ultrasound and aortic staining were performed to examine the pathological features in thoracic aortic tissues. Transwell, wound healing, CCK8, and immunofluorescence assays detected the migration and proliferation of synthetic VSMCs. Egr1 was directly bound to the promoter of Krüppel-like factor 5 (KLF5) and promoted the expression of KLF5, which was validated by JASPAR database and dual-luciferase reporter assay.
Results: Egr1 expression increased and was partially co-located with VSMCs in aortic tissues of mice with TAAD. SMC-specific Egr1 deficiency alleviated TAAD and inhibited the phenotypic switching of VSMC. Egr1 knockdown prevented the phenotypic switching of VSMCs and subsequently suppressed the migration and proliferation of synthetic VSMCs. The inhibitory effects of Egr1 deficiency on VSMCs were blunted once KLF5 was overexpressed.
Conclusion: Egr1 aggravated the development of TAAD by promoting the phenotypic switching of VSMCs via enhancing the transcriptional activation of KLF5. These results suggest that inhibition of SMC-specific Egr1 expression is a promising therapy for TAAD.
Keywords: Egr1; KLF5; phenotypic switching; thoracic aortic aneurysm and dissection; vascular smooth muscle cells.
© 2024 The Author(s). Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society.
Similar articles
-
Semaphorin 3A protects against thoracic aortic aneurysm dissection by suppressing aortic angiogenesis.Angiogenesis. 2025 Jun 28;28(3):39. doi: 10.1007/s10456-025-09992-6. Angiogenesis. 2025. PMID: 40580205
-
ER stress dependent microparticles derived from smooth muscle cells promote endothelial dysfunction during thoracic aortic aneurysm and dissection.Clin Sci (Lond). 2017 Jun 7;131(12):1287-1299. doi: 10.1042/CS20170252. Print 2017 Jun 1. Clin Sci (Lond). 2017. PMID: 28468950 Free PMC article.
-
MMP19 in vascular smooth muscle cells protects against thoracic aortic aneurysm and dissection via the MMP19/Aggrecan/Wnt/β-catenin axis.J Mol Cell Cardiol. 2025 May;202:35-49. doi: 10.1016/j.yjmcc.2025.02.004. Epub 2025 Feb 13. J Mol Cell Cardiol. 2025. PMID: 39954937
-
Unveiling cellular and molecular aspects of ascending thoracic aortic aneurysms and dissections.Basic Res Cardiol. 2024 Jun;119(3):371-395. doi: 10.1007/s00395-024-01053-1. Epub 2024 May 3. Basic Res Cardiol. 2024. PMID: 38700707 Free PMC article. Review.
-
Six Shades of Vascular Smooth Muscle Cells Illuminated by KLF4 (Krüppel-Like Factor 4).Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2693-2707. doi: 10.1161/ATVBAHA.121.316600. Epub 2021 Sep 2. Arterioscler Thromb Vasc Biol. 2021. PMID: 34470477 Free PMC article. Review.
Cited by
-
PIASy deficiency mitigates thoracic aortic aneurysm formation via the TGF-β/Smad2/3 pathway.J Thorac Dis. 2025 May 30;17(5):3400-3409. doi: 10.21037/jtd-2025-984. Epub 2025 May 28. J Thorac Dis. 2025. PMID: 40529770 Free PMC article.
References
REFERENCES
-
- Goldfinger JZ, Halperin JL, Marin ML, Stewart AS, Eagle KA, Fuster V. Thoracic aortic aneurysm and dissection. J Am Coll Cardiol. 2014;64(16):1725‐1739.
-
- Bossone E, Eagle KA. Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes. Nat Rev Cardiol. 2021;18(5):331‐348.
-
- Sen I, Erben YM, Franco‐Mesa C, DeMartino RR. Epidemiology of aortic dissection. Semin Vasc Surg. 2021;34(1):10‐17.
-
- Evangelista A, Isselbacher EM, Bossone E, et al. Insights from the international registry of acute aortic dissection: a 20‐year experience of collaborative clinical research. Circulation. 2018;137(17):1846‐1860.
-
- Milewicz DM, Ramirez F. Therapies for thoracic aortic aneurysms and acute aortic dissections. Arterioscler Thromb Vasc Biol. 2019;39(2):126‐136.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources